Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Anticancer Research|October 3, 2022
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 InhibitorHiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, et al.
Breast Cancer (Tokyo, Japan)|May 18, 2019
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancersYukie Fujimoto, Takahiro Watanabe, Akira I Hida, et al.
Anticancer Research|October 3, 2022
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 InhibitorsHaruka Kanaoka, Masayuki Nagahashi, Yusa Atake, et al.
Oncotarget|February 1, 2020
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancerYoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, et al.
Pageof 2